Düsseldorf, Germany-MEDICA 2023, one of the largest medical B2B trade fairs in the world, was held from November 13 to 16. More than 5300 exhibitors from over 70 countries around world attended this big event. Snibe also showcased its cutting-edge diagnostics technology on the global stage.

The spotlight of our exhibition was Snibe's star products, MAGLUMI X Series which garnered significant attention from attendees. The MAGLUMI X Series comprises the compact MAGLUMI X3, the recently launched flexible MAGLUMI X6, and the ultra-speed MAGLUMI X8, catering to diverse laboratory demands. Each model incorporates our revolutionary X-Tech, delivering an exceptional performance experience.

Additionally, Biossays 240 Plus the fully automatic biochemical analyzer, and Molecision S6 the the Digital PCR System, were also showcased on-site, offering a comprehensive range of laboratory diagnostic solution for our global customers.

With a steadfast focus on chemiluminescence for 28 years, Snibe products have been distributed across 152 countries and regions, with more than 29,500 installations worldwide. Snibe remains committed to providing diverse laboratory diagnostic solutions to global customers. We sincerely appreciate for your participation and eagerly anticipate your presence at MEDICA 2024.